Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Buggisch

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Journal of Gastrointestinal and Liver Diseases : JGLD|March 26, 2016
Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1Tim Zimmermann, Dietrich Hueppe, Stefan Mauss, et al.
Zeitschrift Fur Gastroenterologie|May 13, 2025
Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R)Valerie Ohlendorf, Yvonne Serfert, Peter Buggisch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2009
Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfectionJulian Schulze Zur Wiesch, Dorothea Pieper, Ingrid Stahmer, et al.
Zeitschrift Fur Gastroenterologie|July 15, 2022
Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)Kathrin Krüger, Siegbert Rossol, Christian Krauth, et al.
Journal of Viral Hepatitis|August 2, 2021
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real-world data from the German Hepatitis C-Registry (DHC-R)Dietrich Hüppe, Albrecht Stoehr, Peter Buggisch, et al.
Plos One|June 16, 2022
Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-RegistryMonika Rau, Peter Buggisch, Stefan Mauss, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2011
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatmentJan Grabowski, Cihan Yurdaydìn, Kalliopi Zachou, et al.
Journal of Hepatology|March 4, 2008
Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy studyMaribel Rodríguez-Torres, Sugantha Govindarajan, Ricard Solá, et al.
Zeitschrift Fur Gastroenterologie|January 14, 2020
Management of hepatic encephalopathy in Germany: a survey among physiciansChristian Labenz, Charles C Adarkwah, Marcus-Alexander Wörns, et al.
AIDS (London, England)|November 7, 2006
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infectionEduardo Lissen, Nathan Clumeck, Ricardo Sola, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Journal of Gastrointestinal and Liver Diseases : JGLD|March 26, 2016
Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1Tim Zimmermann, Dietrich Hueppe, Stefan Mauss, et al.
Zeitschrift Fur Gastroenterologie|May 13, 2025
Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R)Valerie Ohlendorf, Yvonne Serfert, Peter Buggisch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2009
Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfectionJulian Schulze Zur Wiesch, Dorothea Pieper, Ingrid Stahmer, et al.
Zeitschrift Fur Gastroenterologie|July 15, 2022
Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)Kathrin Krüger, Siegbert Rossol, Christian Krauth, et al.
Journal of Viral Hepatitis|August 2, 2021
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real-world data from the German Hepatitis C-Registry (DHC-R)Dietrich Hüppe, Albrecht Stoehr, Peter Buggisch, et al.
Plos One|June 16, 2022
Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-RegistryMonika Rau, Peter Buggisch, Stefan Mauss, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2011
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatmentJan Grabowski, Cihan Yurdaydìn, Kalliopi Zachou, et al.
Journal of Hepatology|March 4, 2008
Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy studyMaribel Rodríguez-Torres, Sugantha Govindarajan, Ricard Solá, et al.
Zeitschrift Fur Gastroenterologie|January 14, 2020
Management of hepatic encephalopathy in Germany: a survey among physiciansChristian Labenz, Charles C Adarkwah, Marcus-Alexander Wörns, et al.
AIDS (London, England)|November 7, 2006
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infectionEduardo Lissen, Nathan Clumeck, Ricardo Sola, et al.
Pageof 11